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INTRODUCTION
Research on the impacts of cardiopulmonary 
disease on the lymphatic system has been gaining 
traction as of late. Studies have revealed 
exacerbation of cardiopulmonary disease that is 
caused by lymphatic dysfunction and vice versa. 
Various research hints at the possibility of targeting 
the lymphatic system to ensure and maintain 
cardiopulmonary function. By targeting the 
lymphatic system, researchers hope to delay the 
progression of cardiopulmonary failure exacerbated 
by worsening lymphatic system function by 
rescuing the lymphatic system. More research is 
being conducted to investigate the impact of 
cardiopulmonary disease on the lymphatic system 
to find the extent of damage and the key players and 
mechanism of action to reduce the pathological 
progression of cardiopulmonary disease. 
OBJECTIVE
This research aimed to investigate the effect of 
cardiopulmonary disease and its impact on the 
lymphatic structure. 
METHODS
A total of 9 cadavers were dissected for specific 
regions of the body. The regions were: lumbar, 
common iliac, sacral, internal iliac, external iliac, 
deep inguinal, superficial inguinal, pulmonary, 
cardiac, parasternal, infraclavicular, central axillary, 
pectoral, humeral, subscapular, anterior neck, 
lateral neck, hepatic, kidney, supraclavicular, 
gastric, diaphragmatic, submandibular, submucosal, 
and internal jugular. Some regions were omitted 
from analysis if they failed to meet the range of 
nodes reported per body by various sources as it 
may skew the statistical analysis. Statistical 
analysis was performed utilizing GraphPad Prism 9. 
The mean number of lymph nodes per region and 
mean two-dimensional area of lymph nodes with or 
without disease were compared. A one-tail two-
sample t-test was performed to see if 
cardiopulmonary lymph nodes were statistically 
larger than non-cardiopulmonary lymph nodes. 
Lastly, histological analysis was performed to mark 
any qualitative changes between lymph nodes with 
or without the disease.
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DISCUSSION
More studies should be followed to see the impact of 
cardiopulmonary disease in not just the local 
lymphatic node changes but the systemic changes 
that may occur to the whole lymphatic system. In 
particular, lymphatic vasculature and its dysfunction 
can be a future study to complement the findings of 
this research. Currently, radionuclide 
lymphoscintigraphy using Technetium 99 injected 
sub-dermally is a popular method for assessing 
lymphatic function. Future research depicting the 
change of lymphatic vasculature function in patients 
with cardiopulmonary disease as opposed to those 
who are not suffering from it may be interesting to 
see for seeing the progression of lymphatic 
dysfunction in diseased states. A time-dependent 
change may help provide clues as to potentially 
finding factors that may mitigate or lessen the 
impact of diseased states has on lymphatic 
dysfunction. A significant limitation to this approach 
may be that it will only help assess the level of 
Technetium uptake by lymphatics and its function, 
but its poor resolution will not aid in seeing 
anatomical changes lymphatic vessels may have 
undergone. Future research will need 
complementary methods if it aims to investigate the 
exact mechanism contributing to its dysfunction. 
Additionally, the potential of regulating lymphatic 
vessels via targeting the autonomic nervous system 
has not received as much attention. Researchers 
confirmed that lymphatic endothelial cells are a 
direct target of neurotransmitters and that there are 
nerves closely associated with lymphatic vessels. A 
study involving α1 – adrenergic and muscarinic 
agents and its involvement with lymphatic vessel 
contractility in vivo revealed its ability to modulate 
lymphatic vessel function. Perhaps a study utilizing 
the effect of α1 – adrenergic and muscarinic agents 
and its effect in cardiopulmonary disease patients 
can reveal potential therapeutic benefits. 
Theoretically, improved contractility of lymphatic 
vessels may help lessen the drainage burden and 
improve the cardiopulmonary system's overall 
function. 
